Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Brigitte Bader-Meunier"'
Autor:
Jeremy Levy, Tamás Constantin, Joost Frenkel, Brigitte Bader-Meunier, Anna Shcherbina, Elise L. Dekker, Marco Gattorno, Anna Simon, Inmaculada Calvo, Michael Hofer, Jerold Jeyaratnam, Alberto Martini, Fabrizio De Benedetti, Bas Vastert
Publikováno v:
Rheumatology (Oxford, England)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Rheumatology, 61, 2088-2094
Rheumatology, 61, 5, pp. 2088-2094
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Rheumatology, 61, 2088-2094
Rheumatology, 61, 5, pp. 2088-2094
Objectives To evaluate the long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency during the open label extension (weeks 41–113) of the randomized controlled CLUSTER trial. Methods During a 72-week period, patien
Autor:
Franck Iserin, Rémi Salomon, Laurent Dupic, Jean-Sebastien Diana, François Lefrère, Marianne Delville, Brigitte Bader-Meunier, Christine Bodemer, Florence Lacaille, Mélodie Aubart, Sandrine Zamora, Marina Cavazzana, Laure Joseph, Valerie Jolaine, Sandra Manceau, Nadège Salvi, Christine Barnerias, Tioka Rabeony, C. Chardot, Caroline Elie, Sylvain Renolleau
Publikováno v:
Journal of clinical apheresisREFERENCES. 36(6)
INTRODUCTION Therapeutic plasma exchange (TPE) is acknowledged to be an effective treatment in life-threatening pediatric disorders. Apheresis for pediatric diseases has been poorly investigated, and most studies to date featured small numbers of pat
Autor:
Christine Bodemer, Arnaud Isapof, Cyril Gitiaux, Mathieu P Rodero, Jean-Philippe Herbeuval, Florence Aeschlimann, Brigitte Bader-Meunier, Marie-Louise Frémond, Isabelle Melki, Jean-Luc Charuel, François-Jérôme Authier, Vincent Bondet, Pierre Quartier, Darragh Duffy, Tom Le Voyer
Publikováno v:
Rheumatology
Rheumatology, Oxford University Press (OUP), 2021, pp.keab116. ⟨10.1093/rheumatology/keab116⟩
Rheumatology, 2021, pp.keab116. ⟨10.1093/rheumatology/keab116⟩
Rheumatology, Oxford University Press (OUP), 2021, pp.keab116. ⟨10.1093/rheumatology/keab116⟩
Rheumatology, 2021, pp.keab116. ⟨10.1093/rheumatology/keab116⟩
Objective To evaluate the efficacy and safety of Janus kinase inhibitors (JAKis) in JDM. Methods We conducted a single-centre retrospective study of patients with JDM treated by JAKi with a follow-up of at least 6 months. Proportion of clinically ina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e87c641090e11471439a424d3671230c
https://hal-pasteur.archives-ouvertes.fr/pasteur-03236464/document
https://hal-pasteur.archives-ouvertes.fr/pasteur-03236464/document
Autor:
Nicole Fabien, François Lepelletier, Julien Haroche, Philippe Moguelet, Fleur Cohen Aubart, Brigitte Bader-Meunier, Stéphane Barete, Zahir Amoura, Saskia Ingen-Housz-Oro, Miguel Hie, Makoto Miyara, Philippe Rémy, Camille Francès, Alexis Mathian, S. Grootenboer-Mignot, F. Aucouturier, Tullia de Risi-Pugliese, Noémie Wendremaire
Publikováno v:
Seminars in Arthritis and Rheumatism. 48:83-89
Background Bullous systemic lupus erythematosus (BSLE) is a rare blistering condition associated with systemic lupus erythematosus (SLE). Patients and Methods We conducted a multi-center retrospective study in order to describe the clinical, immunolo
Autor:
Pekka Lahdenne, Tadej Avcin, Stephen D. Marks, Paul A. Brogan, Bas Vastert, Yosef Uziel, Noortje Groot, Angelo Ravelli, Annet van Royen-Kerkhof, Michael W. Beresford, Seza Ozen, Sylvia Kamphuis, Pavla Dolezalova, Nienke de Graeff, Brian M. Feldman, Clarissa Pilkington, Isabelle Koné-Paut, Nico M Wulffraat, Liza J McCann, Brigitte Bader-Meunier
Publikováno v:
Annals of the Rheumatic Diseases, 76(12), 1965-1973. BMJ Publishing Group
Annals of the Rheumatic Diseases, 76(12), 1965. BMJ Publishing Group
ANNALS OF THE RHEUMATIC DISEASES
Annals of the Rheumatic Diseases, 76(12), 1965. BMJ Publishing Group
ANNALS OF THE RHEUMATIC DISEASES
Lupus nephritis (LN) occurs in 50%–60% of patients with childhood-onset systemic lupus erythematosus (cSLE), leading to significant morbidity. Timely recognition of renal involvement and appropriate treatment are essential to prevent renal damage.
Autor:
Salima Hacein-Bey-Abina, Christine Pajot, Isabelle Melki, Jean-Marc Tréluyer, Laure Choupeaux, Sylvaine Poignant, Saik Urien, Aurélia Carbasse, Alexandre Belot, Elodie Henry, Pierre Quartier, Irène Lemelle, Brigitte Bader-Meunier, Roman Krzysiek
Publikováno v:
Seminars in Arthritis and Rheumatism
Seminars in Arthritis and Rheumatism, WB Saunders, 2019, 48 (6), pp.1014-1018. ⟨10.1016/j.semarthrit.2018.09.002⟩
Seminars in Arthritis and Rheumatism, 2019, 48 (6), pp.1014-1018. ⟨10.1016/j.semarthrit.2018.09.002⟩
Seminars in Arthritis and Rheumatism, WB Saunders, 2019, 48 (6), pp.1014-1018. ⟨10.1016/j.semarthrit.2018.09.002⟩
Seminars in Arthritis and Rheumatism, 2019, 48 (6), pp.1014-1018. ⟨10.1016/j.semarthrit.2018.09.002⟩
International audience; Objective: To investigate the relationship of clinical response of Juvenile Idiopathic Arthritis (JIA) to etanercept (ETN) with ETN levels, and the presence of anti-drug antibodies to ETN (ADAb). Methods: Prospective study of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bd7277568e664dd70ee299a21cd4a18
https://hal-cnrs.archives-ouvertes.fr/hal-03295376/document
https://hal-cnrs.archives-ouvertes.fr/hal-03295376/document
Autor:
Gordana Susic, Valda Stanevicha, Ronald Pedersen, Joke Dehoorne, Katarzyna Kobusińska, Jelena Vojinovic, Vyacheslav Chasnyk, Jack F. Bukowski, Luciana Breda, Bogna Dobrzyniecka, Bonnie Vlahos, Irina Nikishina, Ivan Foeldvari, Nico M Wulffraat, Violeta Panaviene, Gerd Horneff, Pavla Doležalová, Zbigniew Zuber, Nicolino Ruperto, Ingrida Rumba-Rozenfelde, Chantal Job-Deslandre, Tamás Constantin, Alberto Martini, Brigitte Bader-Meunier
Publikováno v:
ARTHRITIS RESEARCH & THERAPY
Arthritis Research & Therapy
Arthritis Research and Therapy, 21(1). BioMed Central
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-10 (2019)
Arthritis research and therapy, London : BioMed Central Ltd., 2019, vol. 21, art. no 125, p. [1-10]
Arthritis Research & Therapy
Arthritis Research and Therapy, 21(1). BioMed Central
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-10 (2019)
Arthritis research and therapy, London : BioMed Central Ltd., 2019, vol. 21, art. no 125, p. [1-10]
Background To describe the 6-year safety and efficacy of etanercept (ETN) in children with extended oligoarticular juvenile idiopathic arthritis (eoJIA), enthesitis-related arthritis (ERA), and psoriatic arthritis (PsA) Methods Patients who completed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a24260ebcfda73e8d80147ab182bc9dc
https://biblio.ugent.be/publication/8645026
https://biblio.ugent.be/publication/8645026
Autor:
Alain Fischer, Nizar Malhaoui, Olivier Hermine, Coralie Bloch, Jean-Philippe Jais, Geneviève de Saint Basile, Brigitte Bader-Meunier, Marine Gil, Marouane Boubaya, Felipe Suarez
Publikováno v:
Blood. 134:82-82
Background: Hemophagocytic lymphohistiocytosis (HLH) syndrome is due to an abnormal and sustained activation of T lymphocytes and macrophages releasing pro-inflammatory cytokines in the microenvironment. HLH is characterized by clinical and biologica
Autor:
Joost F Swart, Ariane Klein, Jens Klotsche, Nicolino Ruperto, Angela Pistorio, Ivan Foeldvari, Francesca Bagnasco, Alessandro Consolaro, Valda Staņēviča, AnnaCarin Horne, Francesca Bovis, Jordi Anton, Elena Tsitsami, Еkaterina Alexeeva, Kirsten Minden, Fabrizio De Benedetti, Sylvia Kamphuis, Nico M Wulffraat, Maria Tracahana, Susan Nielsen, Johannes Peter Haas, Gabriella Giancane, Brigitte Bader-Meunier, Alberto Martini, Michael Hofer, Bo Magnusson, Violeta Panaviene, Gerd Horneff, Laura Marinela Ailioaie
Publikováno v:
Arthritis Research & Therapy, 20:285. BioMed Central Ltd.
Arthritis research & therapy, 20(1). BioMed Central
ARTHRITIS RESEARCH & THERAPY
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Arthritis research & therapy, vol. 20, no. 1, pp. 285
Arthritis research and therapy, London : BioMed Central Ltd., 2018, vol. 20, iss. 1, art. no. 285, p. [1-11]
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-11 (2018)
Arthritis Research & Therapy
Arthritis research & therapy, 20(1). BioMed Central
ARTHRITIS RESEARCH & THERAPY
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Arthritis research & therapy, vol. 20, no. 1, pp. 285
Arthritis research and therapy, London : BioMed Central Ltd., 2018, vol. 20, iss. 1, art. no. 285, p. [1-11]
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-11 (2018)
Arthritis Research & Therapy
Background: The availability of methotrexate and the introduction of multiple biological agents have revolutionized the treatment of juvenile idiopathic arthritis (JIA). Several international and national drug registries have been implemented to accu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bcdd4ca65f29113be02f5af41fcde07
https://pure.eur.nl/en/publications/ee7474cb-b162-42a5-983e-d540fc735391
https://pure.eur.nl/en/publications/ee7474cb-b162-42a5-983e-d540fc735391
Autor:
Rémi Salomon, Laurent Dupic, Alix Besançon, Christine Bodemer, Elsa Saire, Karine Brochard, Saoussen Krid, Marianne Delville, Pierre Quartier, Cyril Gitiaux, Brigitte Bader-Meunier, Cécile Talbotec
Publikováno v:
Rheumatology (Oxford, England). 56(10)